Kiniksa Pharmaceuticals International, PLC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Baker Bros. Advisors LP and affiliated entities have waived their right to convert certain shares into Class A ordinary shares of Kiniksa Pharmaceuticals International, plc, to maintain beneficial ownership below 49.9%.